Timothy P. Clackson - ARIAD Pharmaceut

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 136 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Figures 1-6 from Ponatinib (AP24534), a Multitargeted Pan-FGFR Inhibitor with Activity in Multiple FGFR-Amplified or Mutated Cancer Models

Joseph M. Gozgit,Matthew J. Wong,Lauren Moran,Scott Wardwell,Qurish K. Mohemmad,Narayana I. Narasimhan,William C. Shakespeare,Frank Wang,Tim Clackson, Victor M. Rivera

crossref（2023）

Cited0Views0Bibtex

Impact of Early Landmark Responses with Ponatinib on 4-Yr Outcomes in CP-CML Patients (pts) in PACE, a Pivotal Phase II Trial

Martin Mueller,Michele Baccarani,Michael W. N. Deininger,Francois Guilhot,Andreas Hochhaus,Timothy P. Hughes,Neil P. Shah,Moshe Talpaz,Stephanie Lustgarten,Sergio Santillana,Victor M. Rivera,Timothy Piers Clackson,Jorge E. Cortes

Journal of clinical oncology（2017）

Cited1Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn